Corteva, Inc. Earnings Summary — Q1 2026

• Revenue grew 11.05% year-over-year to $4.91 billion, marking a significant rebound from prior quarters.
• Net Income rose to $725 million, supported by operational efficiency and price-mix improvements.
• Operating Income saw a substantial 25.6% year-over-year increase, rising from $805 million to $1.01 billion.
• The company demonstrated strong seasonal momentum with revenue increasing 25% sequentially from Q4 2025.
• Research & Development expenditure reached $341 million in Q1, reflecting ongoing investment in innovation-led growth.
• Selling, General & Administrative expenses were well-controlled, increasing only 16% despite double-digit revenue growth.
• Portfolio simplification efforts are yielding results, with operating margins expanding year-over-year.
• Shareholder alignment remains high through consistent execution on the 'Self-Help' margin expansion phase.

Management remains focused on innovation-led growth and achieving 20%+ EBITDA margin targets through portfolio simplification and cost synergies.

Improving

Revenue and net income growth accelerated compared to the flat or negative growth seen in the tail end of 2025.

The company is well-positioned to leverage its Enlist weed control system and proprietary royalty-saving model to drive future margin expansion and resilient pricing through the remainder of 2026.